Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.

Novartis-Harvard team identifies a new type of cell that is key to the disease.

Novartis team perseveres to develop more personalized approach to breast cancer therapy.

Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.

Novartis researchers are collaborating with tech startup PathAI to search for hidden information in pathology slides.

Boston University developed a methodology to evaluate the impact of Novartis Access in Kenya. Peter C. Rockers tells us about the ongoing study.

Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success

During a three-week maiden voyage to the northern city of Shenyang, the plane's medical volunteers treated 124 patients and provided hands-on surgical training to 18 local doctors.

A conversation with Joachim Momm, head of a Novartis manufacturing site that will be helping to produce Pfizer-BioNTech vaccine doses.

Novartis works tirelessly with third-party organizations to improve access to cancer care.

Healthy Family program combines health education with improved access to doctors and medicines.